HUP0102479A3 - Basbo29 polynucleotides(s) and polypeptides from neisseria meningitidis - Google Patents

Basbo29 polynucleotides(s) and polypeptides from neisseria meningitidis

Info

Publication number
HUP0102479A3
HUP0102479A3 HU0102479A HUP0102479A HUP0102479A3 HU P0102479 A3 HUP0102479 A3 HU P0102479A3 HU 0102479 A HU0102479 A HU 0102479A HU P0102479 A HUP0102479 A HU P0102479A HU P0102479 A3 HUP0102479 A3 HU P0102479A3
Authority
HU
Hungary
Prior art keywords
basbo29
polynucleotides
polypeptides
neisseria meningitidis
meningitidis
Prior art date
Application number
HU0102479A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10831992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0102479(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of HUP0102479A2 publication Critical patent/HUP0102479A2/hu
Publication of HUP0102479A3 publication Critical patent/HUP0102479A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
HU0102479A 1998-05-13 1999-05-07 Basbo29 polynucleotides(s) and polypeptides from neisseria meningitidis HUP0102479A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810276.7A GB9810276D0 (en) 1998-05-13 1998-05-13 Novel compounds
PCT/EP1999/003255 WO1999058683A2 (en) 1998-05-13 1999-05-07 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)

Publications (2)

Publication Number Publication Date
HUP0102479A2 HUP0102479A2 (hu) 2001-10-28
HUP0102479A3 true HUP0102479A3 (en) 2004-10-28

Family

ID=10831992

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102479A HUP0102479A3 (en) 1998-05-13 1999-05-07 Basbo29 polynucleotides(s) and polypeptides from neisseria meningitidis

Country Status (23)

Country Link
US (3) US6780419B1 (https=)
EP (2) EP1621623A3 (https=)
JP (2) JP4707832B2 (https=)
KR (4) KR20080070073A (https=)
CN (1) CN1322127C (https=)
AT (1) ATE311457T1 (https=)
AU (1) AU750032B2 (https=)
BR (1) BR9910396A (https=)
CA (1) CA2328403C (https=)
CY (1) CY1105676T1 (https=)
CZ (1) CZ299612B6 (https=)
DE (1) DE69928658T2 (https=)
DK (1) DK1078063T3 (https=)
ES (1) ES2252946T3 (https=)
GB (1) GB9810276D0 (https=)
HU (1) HUP0102479A3 (https=)
IL (2) IL139613A0 (https=)
NO (2) NO326994B1 (https=)
NZ (1) NZ508323A (https=)
PL (1) PL197449B1 (https=)
TR (1) TR200003347T2 (https=)
WO (1) WO1999058683A2 (https=)
ZA (1) ZA200006523B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
EP1047784B2 (en) † 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Neissera meningitidis antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
CA2371994C (en) 1999-02-26 2010-09-28 Guido Grandi Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
JP2004508801A (ja) 1999-10-29 2004-03-25 カイロン　ソチエタ　ア　レスポンサビリタ　リミタータ ナイセリア抗原性ペプチド
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
PT2289545T (pt) * 2000-01-17 2016-09-06 Glaxosmithkline Biologicals Sa Vacina de omv suplementada contra meningococos
NZ520445A (en) * 2000-01-25 2004-02-27 Univ Queensland Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
NZ521531A (en) 2000-02-28 2005-12-23 Chiron S Heterologous expression of neisserial proteins
ATE469915T1 (de) 2001-07-27 2010-06-15 Novartis Vaccines & Diagnostic Antikörper gegen das meningokokken adhäsin app
US20060057160A1 (en) 2002-08-02 2006-03-16 Ralph Biemans Vaccine composition
HUE031886T2 (en) 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
NZ546430A (en) 2003-10-02 2009-04-30 Novartis Vaccines & Diagnostic Liquid vaccines for multiple meningococcal serogroups
US7459930B2 (en) * 2006-11-14 2008-12-02 Micron Technology, Inc. Digital calibration circuits, devices and systems including same, and methods of operation
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
GB0916570D0 (en) 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method
WO2011110655A2 (en) 2010-03-11 2011-09-15 Glaxosmithkline Biologicals S.A. Vaccine
ES2642184T3 (es) * 2012-01-05 2017-11-15 Deutsches Krebsforschungszentrum Péptidos para su uso en el tratamiento y diagnóstico de cánceres positivos a IDH1 R132H
WO2018022031A1 (en) 2016-07-27 2018-02-01 Prysmian S.P.A. Flexible optical-fiber ribbon

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
RU2023448C1 (ru) 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US5646259A (en) * 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
CU22559A1 (es) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
EP1047784B2 (en) * 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Neissera meningitidis antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
WO2000066741A2 (en) * 1999-04-30 2000-11-09 Chiron S.P.A. Conserved neisserial antigens

Also Published As

Publication number Publication date
NO326994B1 (no) 2009-03-30
WO1999058683A3 (en) 2000-04-06
TR200003347T2 (tr) 2001-06-21
NO20090955L (no) 2001-01-11
ATE311457T1 (de) 2005-12-15
NO20005696D0 (no) 2000-11-10
DK1078063T3 (da) 2006-04-03
BR9910396A (pt) 2001-10-30
DE69928658T2 (de) 2006-06-14
NZ508323A (en) 2002-10-25
EP1078063B1 (en) 2005-11-30
CZ20004202A3 (en) 2001-05-16
US6780419B1 (en) 2004-08-24
CZ299612B6 (cs) 2008-09-17
NO20005696L (no) 2001-01-11
JP2010166921A (ja) 2010-08-05
CN1322127C (zh) 2007-06-20
AU750032B2 (en) 2002-07-11
HK1036300A1 (en) 2001-12-28
US20040265332A1 (en) 2004-12-30
JP2002514424A (ja) 2002-05-21
EP1078063A2 (en) 2001-02-28
IL139613A0 (en) 2002-02-10
IL139613A (en) 2014-03-31
PL197449B1 (pl) 2008-03-31
KR20080070073A (ko) 2008-07-29
EP1621623A3 (en) 2009-02-18
HUP0102479A2 (hu) 2001-10-28
KR100673674B1 (ko) 2007-01-23
ZA200006523B (en) 2001-11-12
ES2252946T3 (es) 2006-05-16
EP1621623A2 (en) 2006-02-01
WO1999058683A2 (en) 1999-11-18
AU4142099A (en) 1999-11-29
GB9810276D0 (en) 1998-07-15
KR20060076789A (ko) 2006-07-04
PL345281A1 (en) 2001-12-03
JP4707832B2 (ja) 2011-06-22
CN1309707A (zh) 2001-08-22
CA2328403A1 (en) 1999-11-18
CA2328403C (en) 2013-11-05
US20090093622A1 (en) 2009-04-09
KR100897951B1 (ko) 2009-05-18
KR20100019461A (ko) 2010-02-18
DE69928658D1 (de) 2006-01-05
CY1105676T1 (el) 2010-12-22
KR20010043571A (ko) 2001-05-25
WO1999058683A9 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
HUP0102479A3 (en) Basbo29 polynucleotides(s) and polypeptides from neisseria meningitidis
EP0980559A4 (en) BIOMETRIC CERTIFICATES
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
IL142122A0 (en) Cyclin d polynucleotides, polypeptides and uses thereof
DE69834346D1 (en) Proteinexpression in baculovirus-vektor expressionsystemen
GB9724783D0 (en) Novel polypeptides
GB9714129D0 (en) Azetidines
IL143600A (en) Il-174 polynucleotides, polypeptides and related compositions and methods
IL128516A0 (en) Isoquinolones
AU137130S (en) Stand mixer
AU3822199A (en) Basb013 dna and proteins from neisseria meningitidis
EP1049708A4 (en) METH1 AND METH2 POLYNUCLEOTIDES AND POLYPEPTIDES
AU5043200A (en) Adam polynucleotides and polypeptides
ZA975748B (en) Portable secure transaction system for programmable terminals and icc's
EP1109454A4 (en) NEISSERIA MENINGITIDIS POLYPEPTID, NUCLEIC ACID SEQUENCE AND USES THEREOF
TW394485U (en) Hinge mechanism and hinge unit
ZA99268B (en) Hm2 cDNA and polypeptide.
AU1780300A (en) Polypeptides and polynucleotides "basb040" from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides
GB9726539D0 (en) Polypeptides, polynucleotides and uses thereof
TW562197U (en) Keyboard device
GB9706817D0 (en) Medical gas mixtures
SI1078063T1 (sl) BASB029 polinukleotidi in polipeptidi iz Neisseria meningitis
GB9717416D0 (en) Polypeptides,polynucleotides and uses thereof
GB9821362D0 (en) Polynucleotides and polypeptides
GB9817303D0 (en) Polypeptides polynucleotides and uses thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees